HUSSMAN STRATEGIC ADVISORS, INC. - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$105,000
-70.6%
15,500
-69.6%
0.02%
-76.6%
Q4 2020$357,000
-57.1%
51,000
-50.0%
0.09%
-57.3%
Q3 2020$832,000102,0000.22%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 572,829$1,340,000100.00%
TRV GP III, LLC 1,148,780$2,688,0001.17%
COWEN AND COMPANY, LLC 3,647,430$8,535,0000.82%
Octagon Capital Advisors LP 1,400,000$3,276,0000.56%
Deep Track Capital, LP 4,259,653$9,968,0000.46%
PFM Health Sciences, LP 4,094,488$9,581,0000.35%
RTW INVESTMENTS, LP 5,106,341$11,949,0000.28%
Omega Fund Management, LLC 275,513$645,0000.24%
Monarch Partners Asset Management LLC 228,370$534,0000.16%
Orbimed Advisors 2,928,900$6,854,0000.13%
View complete list of JOUNCE THERAPEUTICS INC shareholders